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Protein phosphatase 1 (PP1c) is one of the main phosphatases whose function is shaped
by many regulators to confer a specific location and a selective function for this enzyme.
Here, we report that eukaryotic initiation factor 2β of Plasmodium falciparum (PfeIF2β)
is an interactor of PfPP1c. Sequence analysis of PfeIF2β revealed a deletion of 111
amino acids when compared to its human counterpart and the presence of two potential
binding motifs to PfPP1 (29FGEKKK34, 103KVAW106). As expected, we showed that
PfeIF2β binds PfeIF2γ and PfeIF5, confirming its canonical interaction with partners
of the translation complex. Studies of the PfeIF2β-PfPP1 interaction using wild-type,
single and double mutated versions of PfeIF2β revealed that both binding motifs are
critical. We next showed that PfeIF2β is able to induce Germinal Vesicle Break Down
(GVBD) when expressed in Xenopus oocytes, an indicator of its capacity to regulate
PP1. Only combined mutations of both binding motifs abolished the interaction with
PP1 and the induction of GVBD. In P. falciparum, although the locus is accessible
for genetic manipulation, PfeIF2β seems to play an essential role in intraerythrocytic
cycle as no viable knockout parasites were detectable. Interestingly, as for PfPP1, the
subcellular fractionation of P. falciparum localized PfeIF2β in cytoplasm and nuclear
extracts, suggesting a potential effect on PfPP1 in both compartments and raising the
question of a non-canonical function of PfeIf2β in the nucleus. Hence, the role played by
PfeIF2β in blood stage parasites could occur at multiple levels involving the binding to
proteins of the translational complex and to PfPP1.
Keywords: Plasmodium falciparum, Protein Phosphatase type 1, eIF2β, protein-protein interaction, translation
complex
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INTRODUCTION
Malaria, mainly caused by Plasmodium falciparum, is one of
the major parasitic diseases and a leading cause of morbidity
and mortality throughout the tropics and sub-tropics (Burchard,
2014). Although immuno-epidemiological analyses from field
studies suggest that the development of a vaccine is an
achievable goal, it still faces difficulties in order to obtain
high efficiency and sustainable protection (Neafsey et al., 2015;
Partnership, 2015; Richie et al., 2015). These observations
underline the need for continuing efforts to develop novel
antimalarial drugs. The fact that the malaria parasite profoundly
relies on phosphorylation/dephosphorylation post-translational
modifications has meant that its kinases and phosphatases have
been identified as key drug targets (Tewari et al., 2010; Solyakov
et al., 2011; Doerig and Grevelding, 2015; Guttery et al., 2015).
Moreover, in this context, recent reverse genetic studies on the
Plasmodium phosphatome showed that 21 phosphatases out of
67 seem to be essential for parasite survival, including Protein
Phosphatase type 1 (PfPP1) (Guttery et al., 2014).
PP1 is one of the major and most studied Ser/Thr
phosphatases as it dephosphorylates a large number of proteins
in different species. Functional studies show that it is a
much more discriminating enzyme than previously considered
(Bhattacharyya et al., 2002; Fardilha et al., 2010). PP1 is a
holoenzyme composed of a highly conserved catalytic subunit
(PP1c) in association with one or several regulatory subunits.
The latter target PP1c to specific substrates involved in essential
cellular functions such as cell division control and apoptosis
(Bollen, 2001; Ceulemans and Bollen, 2004; Fardilha et al.,
2010). Regulators of PP1c have been shown to be able to
direct its localization and to shape its activity/specificity in a
spatiotemporal manner (Hendrickx et al., 2009; Bollen et al.,
2010). In mammalian cells, it has been shown that the wide
regulatory network of PP1 includes nuclear and cytoplasmic
regulators which control PP1c activity negatively or positively
and prevent the accumulation of free PP1c, which is suggested
to be toxic (Gallego and Virshup, 2005). So far, about 200 PP1
partners/regulators have been described (Heroes et al., 2013). The
functional studies of diverse regulators such as SDS22, Inhibitor-
2, Inhibitor-3, NIPP1, PNUTS, DARPP-32, or MYPT1 (Aggen
et al., 2000; Heroes et al., 2013) considerably contributed to
explaining the capacity of PP1c to participate in a multitude of
cellular functions. Interestingly, human eIF2β, a known member
of the eIF2 complex that controls protein synthesis, has been
shown to bind PP1 (Wakula et al., 2006). This interaction
was confirmed both in vitro and in cell lysates. Furthermore,
the reported data suggest that eIF2β belongs rather to the
regulator/substrate family since binding to PP1 activates the
dephosphorylation of eIF2β but inhibits PP1 activity toward
other substrates (Wakula et al., 2006). Structural and functional
studies revealed that eIF2β contains three domains. The N-
terminal domain involved in the interaction with eIF5 and eIF2B
(Das et al., 1997; Das andMaitra, 2000); the central domain which
is responsible for eIF2γ binding (Thompson et al., 2000) and C-
terminal domain includes a region which participates in mRNA
binding (Laurino et al., 1999).
In P. falciparum, our previous studies showed that the
control of the activity of PP1 is mediated by different conserved
regulators including PfLRR1 (a homolog of yeast SDS22) (Daher
et al., 2006, 2007a,b), Inhibitor-2 (PfI2) (Fréville et al., 2013,
2014) and Inhibitor-3 (PfI3) (Fréville et al., 2012) with substantial
differences compared to I2 and I3 orthologs in humans. Indeed,
PfI2 exhibits an inhibitory role on PfPP1 activity, a canonical
RVxF binding motif not present in human I2 and a peptide
sequence 30% shorter than its ortholog. PfI3, although it contains
the RVxF consensus motif, does not seem to be an inhibitor but
rather an activator of PfPP1 in vitro and is unable to complement
I3 deficient yeast. Whatever the regulatory role played by PfI2 or
PfI3 on PP1 activity, reverse genetic analyses suggest that they are
essential for P. falciparum growth (Fréville et al., 2012, 2013).
Taken together, these observations emphasize the importance
of PP1 regulators and support the further exploration of the
regulatory network of PfPP1. In this context, analyses of the
Plasmodium genome revealed the presence of a putative eif2β
gene (PF3D7_1010600), on chromosome 10 that could be a
partner of PfPP1. Although, the examination of the deduced
amino acid sequence of PfeIF2β showed an unusually short
sequence, truncated at the N-terminal end when compared to
its homologs, it reveals the presence of potential binding motifs
to PP1. In this work, we show that PfeIF2β interacts not only
as expected with PfeIF2γ and eIF5 (partners in the translation
protein complex), but is also a direct interactor of PfPP1. We
further identify two binding motifs in PfeIF2β involved in the
interaction with PfPP1. Structure activity studies reveal that a
combined mutation of these two motifs is critical to completely
inhibit the functional interaction of PfeIF2β with PP1.
MATERIALS AND METHODS
Materials
pCR2.1-TOPO, pETDuet-1, pGEX4T3, and pGADT7 plasmids
were purchased from Invitrogen, Novagen, Life Sciences,
and Clontech respectively. pCAM-BSD and pCAM-BSD-HA
plasmids were kind gifts from Dr. C. Doerig (Monash University,
Melbourne, Australia).
Monoclonal anti-HA, anti-penta His, anti-GST, anti-H3, and
anti-HA peroxidase antibodies were purchased from Roche,
Qiagen, Sigma-Aldrich, Millipore, and Abcam respectively. Anti-
actin1 and anti-SOD1 antibodies were used as previously
described (Daher et al., 2006, 2010).
Sequence Analysis
Putative eIF2β, eIF2γ, and eIF5 sequences were searched using
BLASTp on sequences available in PlasmoDB databases. Protein
sequences (human and P. falciparum) were aligned using the
ClustalW program.
Protein Classification and Phylogenetic
Analyses
The phylogenetic analysis of eukaryotic initiation factor eIF2β
was performed using 76 amino acid sequences of eIF2β from
23 apicomplexans, 5 mammals, 1 amphibian, 8 fish, 9 plants, 8
arthropods, 12 archaea, 1 yeast (fungi), 2 amoebozoa, 1 cercozoa,
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1 foraminifera, and 5 excavata. Before phylogenetic analysis,
sequences were submitted to the protein families database (Pfam,
Finn et al., 2014) and conserved domains (CDD, Marchler-Bauer
et al., 2014) for family and domain assignment, respectively. All
sequences included in further analysis belonged to the eIF5/eIF2B
family (pfam01873), and contained the characteristic structural
domain eIF2β (Accession: PRK03988).
The sequences were aligned with MAFFT (v7), configured
for the highest accuracy (Katoh and Standley, 2013). After
alignment, ambiguous regions were removed with Gblocks
(v0.91b) (Castresana, 2000). The final alignment contained 125
gap free amino acid positions. All evolutionary and phylogenetic
analysis were performed in the Molecular Evolutionary Genetics
Analysis (MEGA, v6) software (Tamura et al., 2013). The best-
fit model of sequence evolution was selected based on Bayesian
Information Criterion (BIC) and Akaike Information Criterion,
corrected (AICc). The JTT (Jones et al., 1992) model with a
proportion of Gamma distributed (G) and invariant (I) sites
which had the lowest values of BIC and AICc was chosen
as best-fitting model for the actual data. The evolutionary
history was inferred using the Maximum Likelihood method
based on JTT model and assuming a proportion of Gamma
distributed (with shape parameter α = 1.19) and invariant sites
(= 0.02). Initial trees for the heuristic search (Nearest-Neighbor-
Interchange: NNI) were obtained by applying Neighbor-Joining
algorithms and the topology with higher log likelihood value
was selected. The reliability of the internal branches was assessed
using the Bootstrap methods with 1000 replicates. Graphical
representation and editing of the phylogenetic trees were
performed with MEGA. The accession numbers of the sequences
are provided in the phylogenetic tree (Figure 2 and Table S2).
Protein Modeling
The Robetta server (http://robetta.bakerlab.org/) was used for
tertiary modeling. The best structure was ranked using the
RESPROX (Berjanskii et al., 2012) qualifying server. Finally,
the structure was prepared using the Schrodinger’s Maestro
(Schrödinger: Schrödinger maestro Package In: maestro, version
99. New York: LLC; 2014) package Protein Preparation Wizard.
The Protein Databank (PDB) crystal structure of Pyrococcus
furiosus (PDB: 2DCU, chain B) was also prepared and used for
a structural alignment of the two initiation factors (implemented
in Maestro). P. furiosus (PDB: 2DCU, chain B) was chosen since
this was the closest structural homolog to P. falciparum eIF2β
according to the Dali server (Holm and Rosenström, 2010).
Preparation of Parasites
P. falciparum 3D7 clone was grown according to Trager et al.
(Trager and Jensen, 1976), with slight modification (Fréville et al.,
2012). Parasites were synchronized by a double sorbitol treatment
as previously described (Vernes et al., 1984).
To isolate total DNA or proteins, parasitized erythrocytes were
lysed by saponin (Umlas and Fallon, 1971) and pelleted. Soluble
proteins extracts were prepared according to Fréville et al. (2013).
Genomic DNA (gDNA) was extracted using the KAPA
Express Extract kit (KAPABioSystem) as described in the
manufacturer’s protocol.
Recombinant Protein Expression and
Purification
The coding regions of PfeIF2β and PfeIF2γ were obtained by
RT-PCR using the primers described in Table S1 and subcloned
in E. coli expression vectors pETDuet-1 and pGEX4T3 which
allows the expression of proteins fused with a 6-His- or GST-
tag respectively. For the expression of PfeIF5 or PfeIF2β in
Xenopus oocytes, they were amplified with p12–p13 and p14–
p15 respectively (Table S1) and subcloned in pGADT7 vector
allowing the production of capped RNA (cRNA) using the T7
promoter. cRNA was obtained as previously described (Fréville
et al., 2014) and used for the expression of HA tagged proteins in
oocytes.
For mutant constructs of PfeIF2β, PCR-based site-directed
mutagenesis (Qbiogene) was used. The pETDuet-PfeIF2β
plasmid was used as template with primers p4–p5
and p6–p7 (Table S1) to obtain PfeIF2β-29AGEAKA34
and PfeIF2β-103KAAA106 respectively. For the PfeIF2β-
29AGEAKA34/103KAAA106 mutant construct, it was obtained
by PCR using the primers p6–p7 and the PfeIF2β-29AGEAKA34
plasmid as template. All the open reading frames (ORFs) as well
as the mutation points were checked by sequencing.
Recombinant Protein Expression and
Antisera Production
Expression and purification of PfPP1 was previously described
(Fréville et al., 2013). The expression of wild PfeIF2β
recombinant protein and the mutated versions were carried
out in the E. coli BL21 strain as previously described (Fréville
et al., 2013) with slight modifications. Briefly, inductions were
carried out at 30◦C for 3 h in the presence of 50 µM ZnCl2 and
tagged-proteins purifications were done under non-denaturing
conditions as described by manufacturers’ protocol using
Ni-NTA agarose beads (Qiagen). The purity, checked by 15%
SDS-PAGE followed by SimplyBlueTM safe staining (Invitrogen),
was>90%. Recombinant PfeIF2β-6His protein was subjeicted to
peptide mass fingerprint by MALDI-TOF mass spectrometry to
confirm its identity.
For the GST tagged proteins, the expression was induced
at 37◦C for 3 h in the presence of 0.5 mM IPTG and 1mM
MnCl2 for PfPP1-GST or 25mM MgCl2 and 50 µM ZnCl2
for the expression of PfeIf2β-GST and PfeIf2γ-GST. Proteins
were purified according to the manufacturers’ instructions using
glutathione Sepharose beads (Sigma). For GST pull down
experiments, purified recombinant proteins were bound to
glutathione-Sepharose beads overnight at 4◦C and washed with
a buffer containing 20mM Tris-HCl pH7.4, 500 mM NaCl, 50
µM ZnCl2, and 0.1% Triton X-100 before use.
The antisera anti-PfeIF2βwas raised according to the protocol
previously described (Fréville et al., 2013).
GST Pull-Down Assays
Two µg of PfeIF2β-6His recombinant protein (wild-type or
mutated) were incubated with PfPP1-GST, PfeIF2γ-GST or GST
bound to gluthatione-Sepharose beads, and 25 µg of BSA in
binding buffer (20 mM Tris-HCl pH7.4, 500mM NaCl, 20
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mM Hepes, 0.2mM EDTA, 0.1% Triton X-100, 1mM DTT,
protease cocktail inhibitor and 1 mM MnCl2, 50 µM ZnCl2
or 25 mM MgCl2 according to uses proteins) for 1–2 h at
4◦C on wheel. After five washes with binding buffer, proteins
were eluted in loading buffer, separated on SDS-PAGE and
blotted to nitrocellulose. Blots were revealed with anti-His or
anti-GST mAb antibodies. Horseradish peroxidase labeled anti-
mouse (1:50,000) was used as secondary antibodies followed by
chemiluminescence detection (DURA, Pierce).
Induction of Xenopus Oocytes GVBD and
Co-immunoprecipitation Experiments
Preparation of Xenopus oocytes and microinjection experiments
were performed as previously described (Vicogne et al., 2004).
Briefly, in each assay, 20 oocytes removed from at least two
or three different animals were microinjected with PfeIF2β-
6His (wild-type or mutated) recombinant protein. Progesterone
was used as a positive control for oocyte maturation. GVBD
was detected by the appearance of a white spot at the
apex of the animal pole after 15 h. In order to carry out
immunoprecipitation, extracts from 20 oocytes removed from
at least two or three animals were prepared 15 min after the
microinjection of PfeIF2β (wild-type or mutated) as previously
described (Vandomme et al., 2014).
Xenopus oocytes were also used in order to test the
interaction of PfeIF2β with its partners PfeIF2γ and PfeIF5.
cRNA corresponding to HA-PfeIF2β or HA-PfeIF5 proteins
was microinjected followed by the microinjection of His-
PfeIF2γ or His-PfeIF2β recombinant proteins respectively.
Protein extractions, immunoprecipitation and immunoblots
experiments were carried out as previously described
(Vandomme et al., 2014).
To examine the interaction of PfeIF2β with XePP1, the
experiments were performed as previously described (Fréville
et al., 2013).
Detection of PfeIF2β in P. falciparum
For western blots, 10 µg/ lane of P. falciparum soluble proteins
from asynchronous cultures was separated on a 4–20% SDS-
PAGE and blotted onto nitrocellulose. For the detection of
PfeIF2β, blots were probed with primary mouse anti-PfeIF2β
serum (1:1000 in PBS milk 5%).
The detection of native PfeIF2β in total proteins extracted
from asynchronous cultures of parasites was carried out by
using PfPP1-6His beads. After pre-clearing on Ni-NTA agarose
beads, 2mg of total protein extracts were incubated at 4◦C
overnight with PfPP1-6His beads. After washing steps, proteins
were eluted with SDS-PAGE loading buffer, separated by SDS-
PAGE and blotted to nitrocellulose. Blots were revealed with pre-
immune serum, anti-PfeIF2β serum, or anti-His mAb antibodies.
Horseradish peroxidase labeled anti-mouse (1:50,000) was
used as secondary antibodies followed by chemiluminescence
detection (DURA, Pierce).
Generation of P. falciparum Transgenic
Parasites
The PfeIF2β disruption plasmid (pCAM-PfeIF2β) was generated
by the insertion of a PCR product corresponding to a 5′ portion
from the PfeIF2β sequence (846 bp) into the pCAM-BSD vector
which contains a cassette conferring resistance to blasticidin. The
insert was obtained using 3D7 genomic DNA as template and
the primers p18–p19 (with PstI and BamHI sites respectively,
Table S1). Attempts to check the accessibility of the PfeIF2β locus
were performed by transfecting wild 3D7 parasites with 3′ tagging
constructs. To this end, the 3′ end of the PfeIF2β sequence (845
bp, omitting the stop codon) was amplified by PCR using 3D7
genomic DNA and the primers p16–p17 (containing PstI and
BamHI restriction sites respectively, Table S1). The 3′ tagging
plasmids were generated by inserting the PCR product into the
pCAM-BSD-hemagglutinin (HA). Ring stage 3D7 parasites were
transfected with 100 µg of plasmid DNA by electroporation,
according to Sidhu et al. (2005). To select transformed parasites,
48 h after transfection, blasticidin antibiotic (Invivogen) was
added to a final concentration 2.5 µg/ml. Resistant parasites
appeared after 4–6 weeks and were maintained under drug
selection.
Genotype and Phenotype Analysis of
P. falciparum Transfectants
To verify the presence of correct constructs in transfected
parasites, plasmid rescue experiments were carried out. Genomic
DNA extracts (KAPA Express Extract) from wild-type or
transfected parasites were used to transform DH5α E. coli cells
(Invitrogen). Plasmid DNA was purified from bacterial clones
and digested with restriction enzymes (PstI and BamHI).
Genotypes of Pfeif2β Knock-Out parasites were analyzed by
PCR on genomic DNA using the primers p24 (derived from
the 5′ non-translated region and absent in the construct) and
p30 (Table S1) specific for the pCAM-BSD vector. Genotypes of
Pfeif2β Knock-In parasites were analyzed using primers p24–p31
(reverse primer corresponding to HA tag, Table S1).
Immunolabeling Assays
Five milliliters of unsynchronized blood cultures of parasites
P. falciparum 3D7 or PfeIF2β-HA recombinant strain (5%
parasitemia) were centrifuged (700 g, 5 min), and the pellet was
fixed 24 h with 10% neutral formalin and paraffin embedded.
Morphological assessment was obtained by examining sections
(4 µm) stained with hematoxylin-eosin-safran.
Immunofluorescence assays (IFA) were done to
immunolocalize PfeIF2β-HA tag recombinant proteins.
Sections of P. falciparum eIF2β-HA tag recombinant strain were
incubated for 1 h at 37◦C with an anti-HA tag (biotine) rabbit
polyclonal antibody (1:100 dilution; Abcam). After washing in
PBS, sections were incubated with streptavidine-Alexa fluor
488-labeled (1:200; Invitrogen) added with 4′,6-diamidino-2-
phenylindole dihydrochloride (DAPI, 0.2 µg/ml; Invitrogen)
for 1 h at 37◦C. After washing, slides were mounted with an
anti-fade mounting medium (Bio-Rad) and analyzed using a
Zeiss LSM880 confocal microscope (Zeiss).
Subcellular Fractionation
The cytoplasmic and nuclear extracts were prepared as previously
described (Voss et al., 2002). Sorbitol synchronized parasites
at ring-stage (10–15 hpi), trophozoite-stage (22–28 hpi), and
schizont-stage (40–42 hpi) were incubated in lysis buffer
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containing 20mM HEPES pH7.8, 10mM KCl, 1mM EDTA,
1mM DTT, 1% Triton X-100, and protease inhibitor cocktail
for 5min on ice. After centrifugation at 2500 g, the supernatants
corresponding to the cytoplasmic fractions were recovered. To
extract the nuclei, the pellets were washed twice with the lysis
buffer and were further incubated in extraction buffer containing
20 mM HEPES pH7.8, 800mM KCl, 1mM EDTA, 1mM DTT,
and protease inhibitor at 4◦C on a rotator for 30min. The
nuclear extracts were centrifuged at 12,000 g for 30min and
the supernatants corresponding to the nuclear extracts were
harvested. Ten micrograms were used in Western blot assays
as described above. The band intensities were quantified using
the Image quant TL8.1 software (GE Healthcare, Imager Las
4000) in which the band intensity of ring nuclear fraction. The
results represent the mean of fold change between nuclear and
cytoplasm fractions.
RESULTS
Sequence Analysis of eIF2β and Its
Expression by P. falciparum
The eIF2β gene bioinformatically identified in the P. falciparum
genome (PfeIF2β) (accession number PF3D7_1010600) encodes
a sequence of 222 amino acids, which is 111 amino acids
shorter than human eIF2β. To clearly identify the ORF of this
gene, PCRs using internal primers of the coding sequence and
primers (Table S1) derived from genomic DNA were performed
on cDNA obtained from total RNA. This approach determined
the start and stop codons with an ORF of 666 nucleotides
(Figure S1). The deduced sequence of 222 amino acids, with
an expected molecular mass of 25.3 kDa, showed an overall
identity with human eIF2β of 47% (Figure 1A). This identity is
mainly observed at the C-terminus (nearly 150 residues) which
contains a conserved region also present in the eIF5 family.
Closer examination of PfeIF2β, revealed the presence of one
lysine block and one GTP binding motif while the human
counterpart contains 3 lysine blocks, known to bind to mRNA,
and 2 GTP binding motifs (Figure 1A). In addition, PfeIF2β
possesses one canonical binding motif, RVxF (103KVAW106) as
well as the FxxR/KxR/K (29FGEKKK34) motif, described to be
involved in binding to PP1. The presence of four conserved
cysteines in PfeIF2β (Figure 1A), known to be involved in the
structural stability of the C-terminus in the presence of Zinc ion
(Gutiérrez et al., 2002), should also be noted.
To further confirm the expression of eIF2β by P. falciparum
at its expected size, an antiserum raised against the His-tagged
recombinant protein (Figure S2) was used in immunoblots on
a total extract of blood parasites from an asynchronous culture.
FIGURE 1 | Molecular cloning, sequences analysis of PfeIF2β and its expression by P. falciparum. (A) Analysis of P. falciparum (PF3D7_1010600) and
human eIF2β (GenBank AAA52383.1). Sequences were aligned using ClustalW Multiple Alignment (BioEdit). The identical and semiconserved amino acids are
highlighted in black and gray respectively. Lysine blocks and GTP binding domains are underlined with orange and blue lines respectively. Green line corresponds to
the domain of the superfamily eIF2/eIF5. The blue boxes contain the≪zinc finger≫ motif (C2-C2motif). The potential PP1-binding motifs “RVxF” and “FxxR/KxR/K”
are in red and green boxes respectively. Phosphorylable amino acids reported in PlasmoDB are in red. (B) Detection of endogenous PfeIF2β in asynchronous cultures
of P. falciparum. Blots were probed with pre-immune serum (lane 1) or with anti-PfeIF2β serum (lane 2). The blots were revealed as described in Section Materials and
Methods.
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As shown in Figure 1B (lane 2), the immunoblot showed a
specific band at 25 kDa confirming the expected size of PfeIF2β
and excluding a longer form of this protein. Proteomic analysis
available at the PlasmoDB revealed that PfeIF2β is expressed
during the intraerythrocytic development of P. falciparum (Pease
et al., 2013).
Phylogenetic Analyses
All sequences included in the phylogenetic analysis belonged
to the eIF-5/eIF-2B family (pfam01873), and contained the
characteristic structural domain eIF-2B (Accession: PRK03988).
The evolutionary history of 76 eIF2β amino acid sequences from
apicomplexan, mammals, amphibian, fish, plants, arthropods,
archaea, fungi, amoebozoa, cercozoa, foraminifera, and excavata
was inferred using the maximum likelihood method based on
the JTT+G+I model (see Section Materials and Methods).
The tree topology with the highest log likelihood is shown
in Figure 2A. The eIF2β of all independent taxa included in
the analysis formed monophyletic clades, except for archaea
that was fractioned in two clusters. The topology of tree
reflects well the current classification of Eukaryotes (Adl et al.,
2012). For example, the eIF2β sequences from Apicomplexan
(Alveolata), Cercozoa and Foraminifera clustered together.
Members of Metazoa (Opisthokonta) formed a monophyletic
clade, but the fungi Schizosaccharomyces pombe (Opisthokonta)
clustered together with Plantae (Archaeplastida) and no with
the Metazoan as expected (Figure 2A). However, the molecular
structure of S. pombe eIF2β resembles that of Metazoan and
no Plantae. A remarkable difference between Opisthokonta and
Archaeplastida eIF2β is that while members of Opisthokonta
present an N-terminus with two lysine blocks, members of
Plantae lack this domain (Figure 2B). The N-terminus is also
absent in Apicomplexa, Amoebozoa, Cercozoa, and Archaea.
Consequently, these groups of organisms do not present the
additional two lysine blocks found in the N-terminus of
Opisthokonta. It is noteworthy that although Reticulomyxa filose
(Foraminifera) and Trypanosoma spp. (Excavata) present an
N-terminus, it is not similar to that found in Opisthokonta
(Figure 2B). From this phylogenetic tree, the most parsimonious
explanation for the evolution of the N-terminal extension is
that it evolved independently in Opisthokonta, Excavata, and
Foraminifera probably and may have different functions within
each of these groups. In agreement with this, the eIF2β from
Excavata and Foraminifera do not present the typical lysine
blocks found in all the other Eukaryotes. Remarkably, despite
the fact that Apicomplexa eIF2β lack the N-terminus, it presents
the two main PP1 binding domains found in Mammals and
Amphibians (FxxR/KxR/K and R/KxV/IxF/W), which suggests a
conserved function (Figure 2B).
Using the Multiple Mapping Method
(http://www.fiserlab.org/servers/M4T), we observed that
the putative tertiary structure of P. falciparum eIF2β (60–201
residues) was similar to the architecture of aIF2β of P. furiosus
(PDB: 2DCU, chain B) with an αββααββαββ topology where the
last two β sheets are conserved for zinc ion binding (Figure 3A).
The helix-turn-helix domain interacts with the γ-domain of
initiation factor (Gutiérrez et al., 2004; Sokabe et al., 2006)
and Figure 3B shows that its position and conformation are
conserved. Since the entire sequence of the β-domain was used,
the modeled P. falciparum eIF2β depicts the additional ∼30
residues extending both termini.
Interaction of PfeIF2β with PfeIF2γ and
PfeIF5
Since eIF2β is known to play a role in the initiation of
translation and had been reported to be a component of the
translational machinery by interacting with eIF2γ and eIF5,
we next examined the ability of PfeIF2β to interact with the
corresponding initiation factors present in P. falciparum. Both
PfeIF2γ (PF3D7_1410600) and PfeIF5 (PF3D7_1206700) were
obtained and sequenced. Deduced amino acid sequence analyses
showed that both proteins exhibited conserved regions known to
be involved in the interaction with eIF2β (Figures S3A,B). The
expression in E. coli of recombinant tagged protein was successful
for PfeIF2γ but failed for PfeIF5, which could be related to the
lack of expression due to the presence of amino acid repeats
and/or to toxicity for bacteria. We then tested by a pull-down
assay whether PfeIF2β interacts with PfeIF2γ. Results presented
in Figure 4A (lane 3) indicated that PfeIF2β was indeed able
to bind GST-PfeIF2γ. The direct interaction was supported
by the absence of eIF2β binding to GST alone (Figure 4A,
lane 2). In an independent approach, we further confirmed
this PfeIF2β-PfeIF2γ interaction using Xenopus oocytes model
where the recombinant cRNA of PfeIF2β (expressing a HA-
tagged protein) and His-tagged recombinant protein PfeIF2γ
were micro-injected. Co-immunoprecipitation with either anti-
His or anti-HA antibodies followed by immnunoblotting analyses
clearly showed an interaction between PfeIF2β and PfeIF2γ
(Figure 4B, lane 3). The use of anti-His or anti-HA antibodies
on extracts from singly micro-injected oocytes (Figure 4B, lanes
1 and 2) confirmed the specificity of the interaction.
To further examine the capacity of PfeIF2β to interact
with PfeIF5, the recombinant cRNA of PfeIF5 (expressing
a HA-tagged protein) and His-tagged recombinant protein
PfeIF2β were micro-injected into Xenopus oocytes. The co-
immunoprecipitation/immunoblot assays clearly revealed an
interaction between PfeIF2β and PfeIF5 (Figure 4C, lane 3).
Taken together, these experiments indicate that the proteins
produced are correctly folded and that PfeIF2β binds to proteins
of the translation initiation eIF complex.
Interaction of PfeIF2β with PfPP1
The presence of two PP1 putative binding motifs in the PfeIF2β
gene product led us to examine the ability of the endogenous
eIF2β expressed by P. falciparum to bind to PfPP1. Pull-
down experiments were carried out using recombinant His-
PfPP1 retained on Ni-NTA agarose beads and a soluble extract
of blood parasites. Eluted proteins with loading buffer were
analyzed for the presence of endogenous PfeIF2β. As expected,
immunoblot with anti-His mAb antibody showed the presence
of His-PfPP1 (Figure 5A, lane 1). When the eluted proteins were
immunoblotted with a polyclonal antibody raised against His-
PfeIF2β, we observed a band at 25 kDa, corresponding to the
expected size of eIF2β. An additional band was detected at 35
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FIGURE 2 | Phylogenetic position and relevant domains of eIF2β from Apicomplexan parasites. (A) The figure displays the maximum likelihood phylogenetic
tree of eIF2β amino acid sequences from 23 apicomplexan, 5 mammals, 1 amphibian, 8 fish, 9 plants, 8 arthropods, 12 archaea, 1 yeast (fungi), 2 amoebozoa, 1
cercozoa, 1 foraminifera, and 5 excavata. All sequences selected for the analysis belonged to eIF5/eIF2B family (pfam01873), and contained the characteristic eIF2B
domain (Accession number: PRK03988). The position eIF2β from P. falciparum is shown (red branch and circle). Numerals at internal branches represent bootstrap
values. Only bootstrap values higher than 50 are shown. The accession number of each sequence is provided in the figure. The name of species was abbreviated as
follow: Apicomplexan: Pfal, Plasmodium falciparum; Pber, P. berghei; Pkno, P. knowlesi; Pviv, P. vivax; Pyyo, P. yoelii yoelii; Prei, P. reichenowi; Pcyn, P. cynomolgi;
(Continued)
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FIGURE 2 | Continued
Pinu, P. inui; Pvvi, P. vinckei vinckei; Bequ, Babesia equi; Bbig, B. bigemina; Bmic, B. microtis; Bbov, B. bovis; Tann, Theileria annulata; Tori, T. orientalis; Tpar, T.
parva; Hham, Hammondia hammondi; Eace, Eimeria acervulina; Ncan, Neospora caninum; Cpar, Cryptosporidium parvum; Cmur, C. muris; Tgon, Toxoplasma
gondii; and Gnip, Gregarina niphandrodes; Mammals: Hsap, Homo sapiens; Mmus, Mus musculus; Btau, Bos taurus; Ggor, Gorilla gorilla; Cfer, Camelus ferus;
Amphibian: Xlae, Xenopus laevis; Fish: Drer, Danio rerio; Ssal, Salmo salar; Eluc, Esox Lucius; Omyk, Oncorhynchus mykiss; Locu, Lepisosteus oculatus; Spar,
Stegastes partitus; Csem, Cynoglossus semilaevis; Nbri, Neolamprologus brichardi; Plant: Atha, Arabidopsis thaliana; Pvul, Phaseolus vulgaris; Csat, Cucumis
sativus; Sind, Sesamum indicum; Csat, Camelina sativa; Vvin, Vitis vinifera; Ptri, Populus trichocarpa; Peu, Populus euphratica; Brap, Brassica rapa; Insects:
Drosophila melanogaster; Ccap, Ceratitis capitata; Bdor, Bactrocera dorsalis; Adar, Anopheles darling; Asin, A. sinensis; Agam, A. gambiae; Mdom, Musca
domestica; Nvit, Nasonia vitripennis; Archeae: Nequ, Nanoarchaeum equitans; Ssol, Sulfolobus solfataricus; PNA2, Pyrococcus sp. NA2; TES1, Thermococcus sp.
ES1; Tbar, T. barophilus; Tgam, T. gammatolerans EJ3; Paby, Pyrococcus abyssi GE5; Pyay, P. yayanosii CH1; Pfur, P. furiosus; Mvan, Methanococcus vannielii SB;
Mkan, Methanopyrus kandleri AV19 ; Smar, Staphylothermus marinus F1; and the Fungi: Spom, Schizosaccharomyces pombe; Amoebozoa: Edis, Entamoeba
dispar; Ehis, Entomoeba histolytica; Cercozoa: Pbra, Plasmodiophora brassicae; Foraminifera: Rfil, Reticulomyxa filose and Excavata: Tviv, Trypanosoma vivax; Tgra,
T. grayi; Tbb, T. brucei brucei; Tbg, T. brucei gambiense; Tcru, T. cruzi. The accession number of each sequence is provided in Table S2. (B) Simplified representation
of eIF2β sequence for each group in the tree. Data regarding functional domains was collected from Asano et al. (1999) and Fréville et al. (2014).
FIGURE 3 | Modeling of the tertiary structure of PfeIF2β. (A) The figure
shows the tertiary structure for the initiation factor of P. falciparum (predicted
model) based on the initiation factor of Pyrococcus furiosus (PDB: 2DCU,
chain B) in 180 turns. The structure is color-coded from the N-terminus (blue)
to the C-terminus (red). The helix-turn-helix (HTH) and the zinc-binding domain
(ZBD) are indicated (colored according to the respective position). The zinc ion
is represented as a gray sphere. (B) The panel is a superposition of the
alpha-carbon backbone of both structures (RMSD = 2.3Å).
kDa which might correspond to His-PfPP1 as the polyclonal
used could contain antibodies against the His-tagged PfeIF2β
used for immunization (Figure 5A, lane 3). Although these data
indicate that endogenous PfeIF2β can bind to PfPP1, it could
not exclude an indirect interaction. In order to examine whether
PfPP1 directly and physically binds PfeIF2β, we performed GST-
pulldown experiments. Figure 5B clearly shows that GST-PfPP1
binds recombinant His-PfeIF2β (lane 3) while GST alone did not
pull down PfeIF2β (lane 2).
To further clarify the molecular basis of interaction of
PfeIF2β with PfPP1, we tried to identify the contribution of
the putative RVxF and FxxR/KxR/K binding motifs present
in PfeIF2β. To this end different versions of mutated PfeIF2β
containing either single or combined mutations of putative
binding motifs (Figure 5C) were used in GST-PP1 pulldown
experiments. Bacterially expressed proteins were purified and
incubated with GST-PfPP1 in vitro. As expected, wild-type
PfeIF2β protein bound PfPP1 (Figure 5D, lane 4). PfeIF2β
proteins with a single mutation in one binding motif (PfeIF2β
103KAAA106 or PfeIF2β 29AGEAKA34) retained their ability to
bind PfPP1 (Figure 5D, lanes 6 and 8 respectively). However,
PfeIF2β protein with combined mutations in the two motifs
(PfeIF2β 29AGEAKA34/103KAAA106) was defective in PfPP1-
binding (Figure 5D, lane 10). GST alone did not pull down wild-
type PfeIF2β or any mutated protein used (Figure 5D, lanes 3,
5, 7, and 9). These data indicate that the RVxF and FxxR/KxR/K
motifs are the central bindingmotifs of PfeIF2β to PfPP1 and that
either native motif is sufficient to mediate binding.
Induction of G2/M Transition of Xenopus
Oocytes by PfeIF2β
To evaluate the impact of PfeIF2β on the activity of PfPP1
and in the absence of Plasmodium specific substrate to this
enzyme, nonspecific substrates such as pNPP or phosphopeptide
(K-R-p-T-I-R-R) were tested. Although PfPP1 was able to
dephosphorylate these substrates, no effect was observed when
PfeIF2β was added at different concentrations (not shown). We
therefore turned our attention to the Xenopus oocyte model
in which the micro-injection of phosphatases regulators could
regulate the G2/M transition assessed by the appearance of
Germinal Vesicle Break Down (GVBD) (Daher et al., 2007a;
Fréville et al., 2013; Vandomme et al., 2014). In this context, we
reasoned that the GVBD could serve as a surrogate marker to
evaluate the functional role of the complex eIF2β-PP1. Using
this model, we first showed that a micro-injection of 60 ng of
recombinant PfeIF2β protein was able to induce GVBD in all
micro-injected oocytes (Figure 6A). To further confirm these
results, wild-type and different single or double mutated PfeIF2β
proteins were used. Results depicted in Figure 6A showed that
all protein versions did induce GVBD except the PfeIF2β double
mutated in RVxF and FxxR/KxR/K motifs. To explain the effect
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FIGURE 4 | Interaction between PfeIF2β and its partners PfeIF2γ and PfeIF5. (A) GST pull-down assays. Glutathione beads alone (lane 1) or coupled with GST
alone (lane 2), or GST-PfeIF2γ (lane 3) were incubated with 6His-tagged PfeIF2β wild-type. After washings, proteins bound to the beads were separated by
SDS-PAGE and blotted to nitrocellulose. Immunoblot (IB) analysis was performed with mAb anti-His antibodies (upper blot) and mAb anti-GST (lower blot). As control,
20% of the input of PfeIF2β protein detected was used and immunoblotted with anti-His antibody (lane 4). (B) Interaction of PfeIF2β with PfeIF2γ in Xenopus oocytes.
His-tagged PfeIF2γ recombinant protein and cRNA of PfeIF2β producing HA-tagged protein were micro-injected in fresh oocytes. Co-immunoprecipitations were
carried out with anti-His (recognizing recombinant PfeIF2γ tagged with 6-His) (upper blot) or with anti-HA (recognizing PfeIF2β tagged HA) (lower blot) antibodies from
micro-injected Xenopus extracts. Immunoprecipitates from Xenopus oocytes micro-injected with cRNA PfeIF2β alone (lane 1), PfeIF2γ protein alone (lane 2), or
PfeIF2β and PfeIF2γ (lane 3) were eluted, separated by SDS-PAGE and transferred to nitrocellulose membrane. Immunoblot (IB) analysis was performed with anti-His
or anti-HA antibodies. (C) Interaction of PfeIF2β with PfeIF5. His-tagged PfeIF2β recombinant protein and cRNA of PfeIF5 producing HA-tagged protein were
micro-injected in fresh oocytes. Co-immunoprecipitations were performed as described in (B). Immunoprecipitates (IP) from Xenopus oocytes micro-injected with
PfeIF5 cRNA alone (lane 1), PfeIF2β protein alone (lane 2), or PfeIF2β and PfeIF5 cRNA (lane 3) were eluted, separated by SDS-PAGE and transferred to nitrocellulose
membrane. Immunoblots were performed as described in (B).
of PfeIF2β in Xenopus oocytes, we checked whether PfeIF2β
could bind to XePP1. Immunoblot analysis of eluates from either
anti-His or anti-XePP1 immunoprecipitations revealed the co-
immunoprecipitation of PfeIF2β and XePP1 (Figure 6B, lane 3).
The single mutation of either RVxF or FxxR/KxR/K motifs did
not affect the binding of PfeIF2β to XePP1 (Figure 6B, lanes 4
and 5) while the double mutation of these two motifs did abolish
the binding capacity of PfeIF2β (Figure 6B, lane 6). Collectively,
these data suggest that PfeIF2β rather blocked the PP1 activity in
oocytes and one of the two bindingmotifs is sufficient for PfeIF2β
to fulfill to its function.
Reverse Genetics in P. falciparum
To explore the role of PfeIF2β in the P. falciparum blood stage life
cycle, silencing its expression by disrupting the gene using the
pCAM vector system was attempted. Blood ring stage parasites
of the 3D7 strain were transfected with a pCAM-BSD-PfeIF2β
construct containing a 5′ fragment derived from the genomic
Pfeif2β sequence and the blasticidin resistance gene (Figure 7A).
From three independent transfection experiments, the analysis of
genomic DNA obtained from resistant stable parasites by PCR
(from 2 months up to 6 months of culture under blasticidin
pressure) with specific primers (Table S1) did not detect the
presence of viable knock out parasites (Figure 7B, lane 6). The
wild type Pfeif2β gene was still amplified in genomic DNA and
the plasmid remained episomal even after prolonged culture
(Figure 7B, lanes 4 and 5 respectively). At this stage, it could
not be excluded that the absence of viable parasites with an
interrupted Pfeif2β gene could be attributed to the lack of
accessibility of Pfeif2β gene locus. To examine this hypothesis,
we introduced a targeted modification in the locus without loss-
of-function by transfecting ring stage parasites with a plasmid
containing the 3′ end of the Pfeif2β coding region fused to theHA
sequence (Figure 8A). Using a specific primer of Pfeif2β derived
from the upstream region of the construct PfeIF2β-HA and a
primer corresponding to the HA sequence (Table S1), genotype
analysis by PCR showed the correct integration of Pfeif2β-HA
into the locus (Figure 8B, lane 4) and indicates the accessibility
of the Pfeif2β locus to genetic manipulations. The integrity of
the HA-tagged PfeIF2β was confirmed by immunoblot using an
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FIGURE 5 | Interaction studies of PfeIF2β with PfPP1. (A) Binding of His-tagged PfPP1 recombinant protein to endogenous PfeIF2β expressed by P. falciparum.
Total soluble proteins extracted from asynchronous cultures (2mg) were pre-cleared on Ni-NTA-agarose beads before and incubated overnight with PfPP1-6His
affinity Ni-NTA column. After washings, eluted proteins were separated by SDS-PAGE and blotted onto nitrocellulose. Using anti-His mAb, lane 1 confirmed the
presence of His-PP1. Pre-immune serum and anti-PfeIF2β antisera were used in lanes 2 and 3 respectively. Lane 3 showed the presence of PfeIF2β. As positive
control, the presence of PfeIF2β in the total parasite extracts using the PfeIF2β antisera is shown in lane 4. (B) Direct binding of PfeIF2β to PfPP1 by GST pull-down
assays. Glutathione beads alone (lane 1) or coupled with GST alone (lane 2), or PfPP1-GST (lane 3) were incubated with 6His-tagged PfeIF2β wild-type. After
washings, proteins bound to the beads were separated by SDS-PAGE and blotted onto nitrocellulose. Immunoblot analysis was performed with anti-His mAb (upper
blot) and anti-GST mAb (lower blot). (C) Scheme representing the different versions of PfeIF2β recombinant proteins (wild-type or mutated) used in this study. (D)
Mapping of PfeIF2β binding motifs to PfPP1. Glutathione agarose beads coupled with GST alone (lanes 1, 3, 5, 7, and 9), or GST-PfPP1 (lanes 2, 4, 6, 8, 10) were
incubated with 6His-tagged PfeIF2β wild-type (lanes 3 and 4), or PfeIF2β 103KAAA106 (lanes 5 and 6), or PfeIF2β 29AGEAKA34 (lanes 7 and 8), or PfeIF2β
103KAAA106/29AGEAKA34 (lanes 9 and 10). After washings, proteins bound to the beads were separated by SDS-PAGE and blotted to nitrocellulose. Immunoblot
analysis was performed with anti-GST mAb (upper blot) and with anti-His mAb (lower blot). The inputs represent 0.5 µg of each 6His-tagged protein (lanes 11, 12, 13,
and 14).
anti-HA monoclonal antibody and protein extracts from Knock-
in parasites (Figure 8C). In order to further explore the knock
in parasites, we attempted to establish stable clonal lines by
limiting dilution. Surprisingly, we were unable to isolate clones
expressing PfeIF2β-HA which could be attributed to the low
efficiency of transfection and recombination in P. falciparum.
Nevertheless, the above data suggest that PfeIF2β is likely
essential for the development of intraerythrocytic stages of P.
falciparum.
Localization and Subcellular Fractionation
of PfeIF2β
In previous report, it has been demonstrated that eIF2β is
exclusively present in cytoplasm of mammalian cells (Bohnsack
et al., 2002). We first sought to investigate the localization of
PfeIF2β in blood stage parasites by IFA. To this end, anti-HA-
biotin antibody (for transfected parasites) or anti-eIF2β antisera
and fixed/permeabilized thin smears of wild parental parasites
on glass slides, fixed/permeabilized parasites in suspension
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FIGURE 6 | Effect of PfeIF2β on GVBD induction in Xenopus oocytes. (A) Induction of Germinal Vesicle Break Down (GVBD) in Xenopus oocytes by PfeIF2β.
Each oocyte was micro-injected with 60 ng of PfeIF2β wild-type, or PfeIF2β 103KAAA106, or PfeIF2β 29AGEAKA34, or PfeIF2β 103KAAA106/29AGEAKA34
recombinant protein. Appearance of GVBD was monitored 15 h after injection. Each experiment was performed using a set of 20 oocytes. Results are presented as
percentage ± SEM of four independent experiments (20 oocytes for each protein). (B) Binding of PfeIF2β to Xenopus oocytes PP1. Co-immunoprecipitation
experiments with anti-His (upper blot) or anti-XePP1 (lower blot) antibodies were carried out on extracts obtained from oocytes micro-injected with wild-type, single
mutated, or double mutated proteins. The anti-mouse IgG antibody was used as a control. Immunoprecipitates from oocytes were eluted, separated by SDS-PAGE
and transferred to a nitrocellulose membrane. Immunoblot analysis was performed with anti-His antibodies (recognizing PfeIF2β) or anti-XePP1 antibodies.
FIGURE 7 | Targeted gene disruption of the PfeIF2β locus. (A)
Gene-targeting construct for gene disruption by single homologous
recombination using pCAM-BSD, and the locus resulting from integration of
the Knock-Out construct. (B) Analysis of pCAM-BSD-PfeIF2β-transfected 3D7
cultures by PCR; lanes 1–3 correspond to DNA extracted from wild-type
parasites; lanes 4–6 correspond to DNA extracted from transfected parasites.
Lanes 1 and 4 represent the detection of the full-length wild-type locus (PCR
with p25 and p28); lanes 2 and 5 represent the detection of episomal DNA
(PCR with p29 and p30); lanes 3 and 6 represent the detection of integration
of the insert (PCR with p24 and p30). The absence of a PCR product in lane 6
indicates the lack of homologous integration.
or thin sections of fixed parasites were used. As shown in
Figure 9A, only the use of anti-HA-biotin antibody combined
with thin sections of fixed parasites resulted in staining of
late transfected parasites (trophozoites, schizonts). The signal
was mainly detectable within the parasite and seems to be
restricted to the cytoplasm as no overlapping was observed
with the nuclear staining. Unfortunately, all assays aiming to
express GFP-tagged PfeIF2β either by episomal expression or
by gene replacement failed so far. The prediction of classical
nuclear localization signals in PfeIF2β (Nguyen Ba et al., 2009)
incited us to further examine the parasite compartments that
contain PfeIF2β using subcellular fractionation method. The use
of cytoplasmic and nuclear markers confirmed the absence of
protein cross contamination during fractionation (Figure 9B,
upper and middle panels). Immunoblots depicted in Figure 9B
(lower part) clearly confirmed the presence of PfeIF2β in
the cytoplasm fraction obtained from asynchronous cultures.
Intriguingly, PfeIF2β was also detectable in the nuclear fraction.
The difference of data between immunoblots and IFA as to
the presence of PfeIF2β in the nucleus could be attributed to
a poor accessibility of the protein and/or its low abundance
in this compartment. When extracts corresponding to about
10 µg of each fraction from synchronized parasite populations
were tested, PfeIF2β was detected in cytoplasm and nuclear
fractions obtained from ring, trophozoite, and schizont stages
(Figure 9C, upper panel). The relative quantification of band
intensities of PfeIF2β revealed about 2.5-fold higher in the
nuclear extracts when compared to the cytoplasm fractions
extracted from ring forms. However, about 11-fold and 10.5-
fold increase were detected in the cytoplasm extracts when
compared to nuclear extracts of trophozoites and schizonts
respectively. When the anti-actin antibody was used, results
Frontiers in Microbiology | www.frontiersin.org 11 May 2016 | Volume 7 | Article 777
Tellier et al. Interaction of PfeIF2β with PfPP1
FIGURE 8 | HA-tagging of the PfeIF2β locus. (A) Epitope tagging of
PfeIF2β by Knock-In strategy. Insertion of an HA epitope tag at the C-terminus
of PfeIF2β single homologous recombination. (B) Analysis of
pCAM-BSD-HA-PfeIF2β-transfected 3D7 cultures by PCR; lanes 1–2
correspond to DNA extracted from wild type parasites; lanes 3–4 correspond
to DNA extracted from transfected parasites. Lanes 1 and 3 represent the
detection of the wild-type locus (PCR with p25 and p28); lanes 2 and 4
represent the detection of integration at the 5′ end of the insert (PCR with p24
and p31). The presence of a PCR product (arrow) and its sequencing
confirmed the integration of a tagged HA-PfeiF2b gene in the locus. (C)
Expression of HA-PfeIF2β was checked by Western-blot with anti-HA-biotin
antibody after separation on SDS-PAGE. Lane 1 represents the culture of
wild-type parasites and lane 2 represents the culture of transfected parasites.
showed that the actin abundance is comparable between
nuclear fractions extracted from ring, trophozoite and schizont
stages (Figure 9C, lower panel). Similar results were obtained
with the actin detected in the cytoplasmic extracts. This
supports the comparison of the level of PfeIF2β in the
same compartment of each stage and further strengthens the
differential distribution of PfeIF2β during the progression of
blood stage parasites.
DISCUSSION
The coordination of PP1 regulatory networks inmammalian cells
and yeast has been extensively examined (Ceulemans and Bollen,
2004) but its study is still in its early stages in P. falciparum.
In previous studies, we have identified and characterized three
PP1 regulators in P. falciparum for which substantial differences
have been observed (protein size and functions) when compared
to their counterparts in mammals. In the present study, we
report the identification of PfeIF2β, a well-known component
of the translational machinery, and show that it directly binds
to PfPP1, although PfeIF2β is 30% shorter than its homologs.
Sequence analyses clearly revealed the absence of 111 amino
acids at the N-terminal region of PfeIF2β. Initial studies carried
out on yeast and human eIF2β have shown that they contain
three different functional regions: the N-terminal, C-terminal,
and the central regions (Hashimoto et al., 2002; Gutiérrez et al.,
2004). The main features of the N-terminal region of the human
eIF2β (residues 1–140), lacking in Plasmodium, are the presence
of three lysine blocks, the eIF5 binding domain (Asano et al.,
1999) and two phosphorylation sites crucial for the control of
protein synthesis. Indeed, mutational studies of Ser2/67 revealed
that these phosphorylation sites are required for its function
(Llorens et al., 2006). Moreover, the overexpression of human
eIF2β with its N-terminal region (residues 2–138) deleted, which
is unable to bind eIF5, has been shown to be highly detrimental to
cell viability (Llorens et al., 2006). These early observations with
our phylogenetic analysis support the idea that the N-terminal
region was acquired during evolution and is likely necessary for
mammals, but it is not present in Plasmodium. Further structural
and functional analyses revealed that the central region of eIF2β
is essential for its interaction to eIF2γ subunits (Hashimoto
et al., 2002), providing a platform for protein synthesis initiation
(Sokabe et al., 2006; Yatime et al., 2007). Consequently, we cloned
PfeIF2γ and examined its capacity to interact with PfeIF2β. Our
results showed that PfeIF2β was able to bind PfeIF2γ, supporting
the role of conserved regions in PfeIF2β and the tertiary structure
proposed in this study (Figures 2, 3). The discovery that the
PfeIF2β sequence contains 2 potential motifs for binding to
PP1 has naturally raised the question of its capacity to carry
out this function. PfeIF2β contains the canonical RVxF binding
motif (KVAW), (also present in Amphibians and mammals) and
the FxxR/KxR/K motif (FGEKKK). We have demonstrated that
the endogenous eIF2β expressed by P. falciparum as well as
the recombinant PfeIF2β protein were able to bind PfPP1. This
indicates that PfeIF2β directly interacts with PfPP1 and that post-
translational modifications are not a prerequisite for the binding.
Furthermore, we have shown by independent experimental
approaches that the putative RVxF and FxxR/KxR/K motifs
present in the N-terminal region are both functional and their
combined mutations completely abolished the interaction with
PfPP1. Our results are in agreement with previous studies
showing the involvement of the RVxF motif in human eIF2β
binding. However, it has been suggested that human eIF2β
harbors a second binding motif, yet to be determined, present
in the C-terminal domain (between residues 187 and 314)
(Wakula et al., 2006), reinforcing the idea that a different
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FIGURE 9 | Localization of PfeIF2β. (A) Immunolocalization assays. Asynchronous cultures of PfeIF2β-HA tag recombinant strain of P. falciparum 3D7 were fixed
with formalin and paraffin embedded. Sections were incubated with an anti-HA tag (biotin) antibody recognized by a streptavidine-Alexa fluor 488-labeled conjugated
added with DAPI to label nuclei. Fluorescence staining was analyzed using a Zeiss LSM880 confocal microscope. The merged image of the double stained
(PfeIF2β-HA tag, DAPI) and differential interference contrast (DIC) images are also presented. Immunofluorescence assays revealed a cytoplasmic localization of
PfeIF2β in the trophozoite (panel 1), young schizont (panel 2), or mature schizont (panel 3) stages. Note that no staining was observed in ring-stage. No staining was
observed when the primary antibody (anti-HA) was omitted (not shown). Bar = 5 µm. (B) Immunoblot analysis on nuclear and cytoplasm fractions from asynchronous
parasites cultures. The quality control of nuclear (N) and cytoplasm (C) fractions were checked using Anti-SOD1 (upper panel) and anti-H3 antibodies (middle panel)
respectively. The (lower) panel showed the presence of PfeIF2β in both fractions. (C) A representative Western blot assay showing the detection of PfeIF2β in
cytoplasm and nuclear extracts (upper panel) from ring-stage (R), trophozoit-stage (T), and schizont-stage (S). Equal amount of nuclear and cytoplasmic proteins (10
µg) extracted from each stage were loaded. The (lower) panel showed the detection of Pf-actin 1 in the different nuclear and cytoplasmic fractions used.
mode of interaction between PfeIF2β and PfPP1 occurs in
Plasmodium.
To further examine the interaction of PfeIF2β-PP1 by
functional assay, Xenopus oocytes, which are arrested in G2/M
prophase I under physiological conditions, were used. In this
model, the micro-injection of wild-type PfeIF2β, RVxF-mutated
PfeIF2β, or FxxR/KxR/K-mutated PfeIF2β protein induced
GVBD. However, the use of the double mutated version of
PfeIF2β did not promote the induction of GVBD, which is
in line with the incapacity of the double mutated protein
to interact with XePP1 (Figure 6B). These data confirm the
PfeIF2β-PP1 interaction and support the idea that PfeIF2β, in
this model, is rather an inhibitor of PP1 since it has been
reported that the inhibition of XePP1 by different regulators
or the use of anti-PP1 antibodies did induce GVBD (micro-
injection of LRR1, I2, PP1 antibodies). From these experiments,
it cannot be excluded that the micro-injected PfeIF2β could be
phosphorylated in oocytes, leading to an inhibitory function
of PP1 in a cellular context. It is important to note that
PfeIF2β is subjected to phosphorylation since phosphoproteome
analyses showed the presence of phosphorylated Ser23/205 and
Thr90, raising the hypothesis that phospho-PfeIF2β could be
required to impact the activity of PfPP1. Supporting this is
the fact that, although recombinant PfeIF2β binds to PfPP1 in
vitro, it did not affect the PfPP1 activity against either pNPP
or small phosphopeptide. However, this should await further
characterization of physiological substrates in P. falciparum to
conclude about the role of PfeIF2β on PfPP1.
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The analysis of cellular distribution of PfeIF2β revealed,
as expected, its presence in the cytoplasm compartment. This
localization and the capacity of PfeIF2β to bind eIF2γ and
eIF5 likely support its canonical function in protein synthesis
(Asano et al., 1999; Das and Maitra, 2000; Yatime et al., 2007).
However, one of the most striking observations is the detection
of PfeIF2β by immunoblot in the nuclear fraction under normal
growth conditions. This could be an active process as PfeIF2β
contains a potential nuclear localization signal. The presence
of PfeIf2β in nuclear fraction could not be linked to the
presence of Endoplasmic Reticulum (ER) associated organelles
as the ER gradually increases during the growth of blood stage
parasites (van Dooren et al., 2005). During the progression
of the intraerythrocytic life cycle which coincides with an
increase of the rate of translation (Foth et al., 2011), PfeIF2β
shifted from the nucleus to the cytoplasm compartments. In
higher eukaryotes, the shift of eIF2β localization from cytoplasm
to nuclear localization can be only observed when a specific
inhibitor of nuclear export was used (Bohnsack et al., 2002),
suggesting a transient role of eIF2β in the nucleus. Our results
combined with previous proteomic study reporting the detection
of PfeIF2β in the nuclear proteome (Oehring et al., 2012) strongly
suggest an unexpected steady role for this eIF2β related protein
in the nucleus and mainly at the ring stage where the highest
accumulation was detected. Given that we and others showed
that PP1 is also nucleo-cytoplasmic, we could not rule out
that PfeIF2β could interact/regulate PP1 in both compartments
(Daher et al., 2006; Guttery et al., 2014). Another interesting
point is that PfeIF2β can exert other functions since an earlier
study reported that human eIF2β was phosphorylated by a
nuclear kinase and could be a part of a protein-DNA complex
(Ting et al., 1998).
Finally, in an attempt to explore the role of eIF2β in
P. falciparum life cycle, we tried to disrupt its gene. Our
studies most probably suggest an essential role for PfeIF2β
in blood stage parasites, which is expected as eIF2β is
required for the translation initiation complex. This is in
agreement with earlier studies indicating that a deficiency
in eIF2β expression in mice (eIF2S2), affects embryonic
and germ cell proliferation and causes embryonic death
(Heaney et al., 2009). These observations, along with the
considerable difference of the gene product size of mammalian
eIF2β and PfeIF2β and the divergence of the motifs/regions
involved in the binding of PfeIF2β to its partners, it appears
that interfering specifically on PfeIF2β functions could be
conceivable and could represent an attractive approach for
pharmacological intervention to control and inhibit Plasmodium
growth.
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